Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
204.00
-1.04 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
203.05
-0.95 (-0.47%)
After-hours: Dec 5, 2025, 7:51 PM EST
Insmed Stock Forecast
Stock Price Forecast
According to 17 professional analysts, the 12-month price target for Insmed stock ranges from a low of $115 to a high of $256. The average analyst price target of $178.71 forecasts a -12.40% decrease in the stock price over the next year.
Price Target: $178.71 (-12.40%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 8 | 8 | 8 | 7 | 7 | 7 |
| Hold | 0 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 19 | 19 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $196 → $256 | Buy | Maintains | $196 → $256 | +25.49% | Dec 1, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $223 → $231 | Strong Buy | Maintains | $223 → $231 | +13.24% | Nov 20, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $171 → $217 | Buy | Maintains | $171 → $217 | +6.37% | Oct 31, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $196 → $225 | Strong Buy | Maintains | $196 → $225 | +10.29% | Oct 31, 2025 |
| UBS | UBS | Strong Buy Maintains $194 → $223 | Strong Buy | Maintains | $194 → $223 | +9.31% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
520.48M
from 363.71M
Increased by 43.10%
Revenue Next Year
1.19B
from 520.48M
Increased by 128.25%
EPS This Year
-6.22
from -5.57
EPS Next Year
-3.73
from -6.22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 567.5M | 1.6B | ||||
| Avg | 520.5M | 1.2B | ||||
| Low | 440.0M | 882.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 56.0% | 200.5% | ||||
| Avg | 43.1% | 128.3% | ||||
| Low | 21.0% | 69.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.37 | -2.60 | ||||
| Avg | -6.22 | -3.73 | ||||
| Low | -6.62 | -5.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.